Associations between the intratumoral microbiome and the host transcriptome in bladder cancer and their implications for prognostic prediction.

Authors

Jiayu Gu, Menglin Wang, Zhihao Zhou, Minhao Zhang, Hao Lin, Ye Hua, Dong Zhang, Jianfeng Shao, Ninghan Feng

Published in

Scientific reports. Jul 11, 2026. Epub Jul 11, 2026.

Abstract

Intratumoral microbes significantly influence tumor progression, yet their specific roles and host interactions in bladder cancer (BLCA) remain elusive. Integrating 16 S rRNA sequencing from an in-house cohort with TCGA data, we identified Methylobacterium as prominently enriched in adjacent non-tumor tissues and tightly correlated with host transcriptomic alterations. Through LASSO regression, we constructed and externally validated a Methylobacterium-associated four-gene prognostic signature (SLC1A6, BCHE, TXNRD1, CFL2). The model robustly stratified patient outcomes; high-risk patients exhibited significantly worse survival, characterized by an immunosuppressive microenvironment with elevated M2 macrophages, regulatory T cells, and higher TIDE scores indicating immune evasion. Crucially, in vitro experiments suggested that Methylobacterium supernatant exerted tumor-suppressive effects, profoundly inhibiting BLCA cell proliferation and colony formation while modulating host gene expression (downregulating BCHE and CFL2). Collectively, this study unveils the protective potential of intratumoral Methylobacterium and proposes a novel microbe-derived signature for predicting BLCA prognosis and immune status, providing new insights into microbiota-host crosstalk for future therapeutic strategies.

PMID:
42436233
Bibliographic data and abstract were imported from PubMed on 12 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.